Prostate cancer tops the list of cancers in men, second only to skin cancer. According to the American Cancer Society, one out of seven men are diagnosed with prostate cancer, affecting more than 233,000 men each year and killing almost 30,000 annually. If caught early, prostate cancer is 90-95 percent curable, making screenings all the more important.
The future of cancer therapy may lie in the very stem cells that cause cancer in the first place. Researchers at the Texas A&M Institute of Biosciences and Technology are studying how stem cells that cause cancer come out of dormancy and become active. If they can keep the cells dormant, they can ultimately prevent cancer from forming.
Researchers at the Texas A&M Health Science Center (TAMHSC) Institute of Biosciences and Technology in Houston have identified a biomarker that will aid in more accurately determining the prognosis for prostate cancer patients, a finding that could have further implications for anti-cancer drug discovery and ultimately, cancer prevention.